Piper Sandler Maintains Neutral on Rigel Pharmaceuticals, Raises Price Target to $23
Rigel Pharmaceuticals Analyst Ratings
Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $49
H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57
Rigel Pharmaceuticals Analyst Ratings
H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57
Rigel Pharmaceuticals Price Target Maintained With a $15.00/Share by Cantor Fitzgerald
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $57 Price Target
Rigel Pharmaceuticals Analyst Ratings
H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57
HC Wainwright & Co. Maintains Buy on Rigel Pharmaceuticals, Adjusts Price Target To $57 (1-20 Reverse Stock Split)
Rigel Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target
Rigel Pharmaceuticals Analyst Ratings
Rigel Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target
Rigel Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target
HC Wainwright & Co. : Rigel Pharmaceuticals (RIGL.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $15.00.
Rigel Pharmaceuticals Analyst Ratings